Iqvia Holdings Inc.

Organisation

2400 Ellis Road, Durham, NC, United States, 27703

Headquarters

93000

Employees

Health Services

Industry

Ari Bousbib

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

Price

Target

Iqvia Holdings Inc. (IQV) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Iqvia Holdings Inc. (IQV) share price will touch around $236.19 in next 12-months.

Currently 26 wall-street analysts regularly analyze the financials of Iqvia Holdings Inc. on a frequent basis to provide recommendations along with target share price. 26 analysts offering 12-month price forecasts for Iqvia Holdings Inc. (IQV) have a share price target of $236.19. This median of share price forecast represents a 39.9% upside from the latest price of $168.83 as on 26.03.26.

Iqvia Holdings Inc. (IQV) Share Price Forecast

Home

US Stocks

Iqvia Holdings Inc. (IQV)

Iqvia Holdings Inc. Stock Forecast

Iqvia Holdings Inc. Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Iqvia Holdings Inc. (IQV): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Iqvia Holdings Inc.'s share price and its median forecast price. As on 26.03.26, the difference is -10.03%

Iqvia Holdings Inc. Forecast and Target Price

Iqvia Holdings Inc. (IQV) Share Price Forecast

Iqvia Holdings Inc. (IQV) Price vs Consensus Price Target

Iqvia Holdings Inc. (IQV) Share Price Forecast v/s Share Price Today

Iqvia Holdings Inc. (IQV): Difference between Current Price & Median Forecasted Price

Iqvia Holdings Inc. (IQV) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price